Cagrilintide 5mg

Cagrilinitide (or “Cagri”) is a long-acting, lipidated, albumin-binding amylin agonist that targets both amylin and calcitonin receptors. It is used in the treatment of obesity, either on its own or in combination with GLP-1 receptor agonists. Amylin is co-secreted with insulin from pancreatic beta cells and regulates appetite, satiety, gastric emptying, and glucose control.

Combining Cagrilinitide with a GLP-1 like Semaglutide has a synergistic effect, amplifying weight loss beyond what either peptide achieves independently. Other benefits include improved circulation, reduced blood pressure, enhanced bone-building activity, and vasodilation.

Outcomes

• 6–10% body weight loss at 26 weeks (Cagrilinitide alone)

• 23–24.4% body weight loss at 68 weeks (combined with Semaglutide)

• Synergistic effect: up to 8% more weight loss vs. Semaglutide alone

For laboratory research use only. Not for human or veterinary use.

What’s Included in Your Kit:

Your selected peptide

Bacteriostatic water

8× alcohol pads

6× insulin/dosage syringes

1× 3cc syringe for reconstitution

Packaged securely in a durable hard plastic case

Note: “Vial Only” refers to the peptide vial only and does not include any additional tools or accessories.